PYRROLOBENZODIAZEPINKONJUGATE
European patent · EP3668874 · In force
Register entry
- Publication number
- EP3668874
- Application number
- EP18758581
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 17, 2018
- Published
- Jun 24, 2020
- Granted
- Dec 22, 2021
- Protection ends at the latest
- Aug 16, 2038
- Next annual fee due
- Aug 31, 2026
- IPC classes
- A61K 31/5517 (2006.01)C07K 16/30 (2006.01)A61K 47/68 (2017.01)A61K 45/06 (2006.01)A61K 39/00 (2006.01)A61P 35/00 (2006.01)C07K 16/32 (2006.01)C07D 519/00 (2006.01)C07D 487/04 (2006.01)
- Priority
- US 201762547303 P 18.08.2017
- PCT application
- PCT/EP2018/072298 17.08.2018
- PCT publication
- WO2019/034764 21.02.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2025
Change
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Change
Published in Swissreg on 01.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Nov 2, 2022
Change
Published in Swissreg on 02.11.2022
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- Feb 18, 2022
Agent entered
- Representative
- MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex
Published in Swissreg on 18.02.2022
- Dec 22, 2021
Granted
Published in Swissreg on 22.12.2021
Parties
Inventor
Cambridge Cambridgeshire CB21 6GH, GB
Cambridge Cambridgeshire CB21 6GH, GB
Gaithersburg, MD 20878, US
Cambridge Cambridgeshire CB21 6GH, GB
Cambridge Cambridgeshire CB21 6GH, GB
Gaithersburg, MD 20878, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.